P2.04-27 Ph II Study of Oral Selective AXL Inhibitor...

Journal of Thoracic Oncology 2018 / 10 Vol. 13; Iss. 10

P2.04-27 Ph II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in Patients with Advanced NSCLC

Arce-Lara, C., Arriola, E., Brunsvig, P., Carcereny, E., Domine, M., Dragnev, K., Felip, E., García Campelo, R., Krebs, M., Paz-Ares, L., Ponce Aix, S., Spicer, J., Trigo, J.M., Vinolas Segarra, N., H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.1251
Date:
October, 2018
File:
PDF, 147 KB
english, 2018
Conversion to is in progress
Conversion to is failed